Everolimus, generally sold under the trade name Afinitor, is classified as an “mTOR kinase inhibitor”. It is a key medication that functions as an immunosuppressant to prevent rejection of organ transplants by decreasing the activity of the immune system. It also finds usage in the treatment of renal cell cancer and other tumours, especially progressive...Continue Reading